Reviva Pharmaceuticals Hldg Inc
(RVPH)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 13,183 | 10,364 | 5,289 | 13,476 | 5,559 |
| TOTAL | $13,513 | $10,815 | $6,257 | $14,683 | $6,810 |
| Non-Current Assets | |||||
| Other Non-Current Assets | 820 | 820 | 820 | 820 | 820 |
| TOTAL | $820 | $820 | $820 | $820 | $820 |
| Total Assets | $14,333 | $11,635 | $7,077 | $15,503 | $7,630 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 5,432 | 4,969 | 4,721 | 6,283 | 8,778 |
| Accrued Expenses | 3,676 | 6,073 | 6,081 | 7,359 | 8,245 |
| TOTAL | $9,738 | $12,077 | $11,509 | $14,602 | $17,534 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 45 | 17 | 28 | 89 | 78 |
| TOTAL | $45 | $17 | $28 | $89 | $78 |
| Total Liabilities | $9,783 | $12,094 | $11,537 | $14,691 | $17,612 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 115,059 | 68,004 | 46,740 | 46,740 | 33,441 |
| Common Shares | 10 | 7 | 5 | 5 | 3 |
| Retained earnings | -180,770 | -176,760 | -170,706 | -164,273 | -158,014 |
| TOTAL | $4,550 | $-459 | $-4,460 | $813 | $-9,982 |
| Total Liabilities And Equity | $14,333 | $11,635 | $7,077 | $15,503 | $7,630 |